Noxopharm Ltd
ASX:NOX
Prices of ASX stocks are not being updated. The latest NOX price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Noxopharm Ltd (NOX) under the Base Case is AUD per share.
Compared with the last price of 0.055 AUD on Oct 14, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Noxopharm Does
Noxopharm Ltd is an Australian drug-development company that works on new medicines for cancer and immune-related diseases. It does not run a pharmacy or sell finished medicines to consumers. Instead, it discovers drug candidates, tests them in preclinical and clinical studies, and tries to move the most promising ones toward licensing or partnership deals.
- Headquarters
- Australia AU
- Employees
- 1 000
- IPO date
- Aug 9, 2016
Earnings Waterfall
Noxopharm Ltd
What is the Intrinsic Value of one NOX stock?
The intrinsic value for Noxopharm Ltd (NOX) under the Base Case is AUD.
Is NOX stock undervalued or overvalued?
Compared with the last price of 0.055 AUD on Oct 14, the stock appears .
